torcetrapib has been researched along with proline in 1 studies
| Studies (torcetrapib) | Trials (torcetrapib) | Recent Studies (post-2010) (torcetrapib) | Studies (proline) | Trials (proline) | Recent Studies (post-2010) (proline) |
|---|---|---|---|---|---|
| 273 | 28 | 83 | 22,134 | 520 | 5,973 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnette, P; Durham, LK; Freeman, TB; Lanzetti, A; Lira, ME; Lloyd, DB; Milos, PM; Preston, GM; Qiu, X; Sugarman, E; Thompson, JF; Wood, LS | 1 |
1 trial(s) available for torcetrapib and proline
| Article | Year |
|---|---|
Cholesteryl ester transfer protein variants have differential stability but uniform inhibition by torcetrapib.
Topics: Adult; Aged; Cardiovascular Diseases; Carrier Proteins; Cell Line; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Crystallography, X-Ray; DNA, Complementary; Female; Genome, Human; Glutamine; Glycoproteins; Humans; Inhibitory Concentration 50; Lipoproteins, HDL; Male; Middle Aged; Models, Molecular; Mutation, Missense; Polymorphism, Single Nucleotide; Proline; Protein Binding; Protein Conformation; Quinolines; Transcription, Genetic | 2005 |